Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

Autor: Turkova A; Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: a.turkova@ucl.ac.uk., White E; Medical Research Council Clinical Trials Unit at University College London, London, UK., Kekitiinwa AR; Baylor College of Medicine, Kampala, Uganda., Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Kaudha E; Joint Clinical Research Centre, Kampala, Uganda., Liberty A; Perinatal HIV Research Unit, University of the Witwarsrand, Johannesburg, South Africa., Ahimbisibwe GM; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Moloantoa T; Perinatal HIV Research Unit, University of the Witwarsrand, Johannesburg, South Africa., Srirompotong U; Pediatric Department, Khon Kaen Hospital, Thailand., Mosia NR; Department of Paediatrics and Children Health, King Edward VIII Hospital, Enhancing Care Foundation, University of KwaZulu-Natal, Durban, South Africa., Puthanakit T; HIVNAT, Thai Red Cross AIDS Research Center, Bangkok, Thailand; Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Thailand., Kobbe R; Institute for Infection Research and Vaccine Development, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Department of Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Fortuny C; Infectious Diseases Department, Institut de Recerca Sant Joan de Déu, Sant Joan de Déu Children's Hospital, Barcelona, Spain; Department of Surgery and Medico-Surgical Specialties, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Kataike H; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda., Bbuye D; Baylor College of Medicine, Kampala, Uganda., Na-Rajsima S; Pediatric Department, Mahasarakam Hospital, Thailand., Coelho A; INSERM/ANRS SC10-US19, Essais Thérapeutiques et Maladies Infectieuses, Villejuif, France., Lugemwa A; Joint Clinical Research Centre, Mbarara, Uganda., Bwakura-Dangarembizi MF; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Klein N; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, UK; Africa Health Research Institute, Kwazulu-Natal, South Africa., Mujuru HA; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Kityo C; Joint Clinical Research Centre, Kampala, Uganda., Cotton MF; Children's Infectious Diseases Clinical Research Unit, Family Center for Research with Ubuntu, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa., Ferrand RA; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK., Giaquinto C; Department of Women and Child Health, Padova, University of Padova, Italy., Rojo P; Pediatric Infectious Diseases Unit, Hospital 12 de Octubre, Madrid, Spain., Violari A; Perinatal HIV Research Unit, University of the Witwarsrand, Johannesburg, South Africa., Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, UK., Ford D; Medical Research Council Clinical Trials Unit at University College London, London, UK.

Publikováno v: The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2023 Oct; Vol. 7 (10), pp. 718-727. Date of Electronic Publication: 2023 Aug 08.

Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population.

Autor: Samaneka WP; University of Zimbabwe-University of California San Francisco Collaborative Research Programme, Harare, Zimbabwe., Mandozana G; Department of Community Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe., Tinago W; Department of Community Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Nhando N; University of Zimbabwe-University of California San Francisco Collaborative Research Programme, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe-University of California San Francisco Collaborative Research Programme, Harare, Zimbabwe., Bwakura-Dangarembizi MF; Department of Pediatrics, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Munjoma MW; University of Zimbabwe-University of California San Francisco Collaborative Research Programme, Harare, Zimbabwe.; Department of Obstetrics and Gynecology and Reproductive Health Sciences, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Gomo ZA; Department of Chemical Pathology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Chirenje ZM; University of Zimbabwe-University of California San Francisco Collaborative Research Programme, Harare, Zimbabwe.; Department of Obstetrics and Gynecology and Reproductive Health Sciences, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Hakim JG; University of Zimbabwe-University of California San Francisco Collaborative Research Programme, Harare, Zimbabwe.; Department of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.

Publikováno v: PloS one [PLoS One] 2016 Nov 03; Vol. 11 (11), pp. e0165821. Date of Electronic Publication: 2016 Nov 03 (Print Publication: 2016).

Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.

Autor: Nahirya-Ntege P; MRC/UVRI Uganda Research Unit on AIDS, Uganda Virus Research Institute, Entebbe, Uganda., Musiime V, Naidoo B, Bakeera-Kitaka S, Nathoo K, Munderi P, Mugyenyi P, Kekitiinwa A, Bwakura-Dangarembizi MF, Crawley J

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2011 Jun; Vol. 30 (6), pp. 535-7.